432 results on '"Sung, Anthony D."'
Search Results
52. A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease
53. Prebiotic galactooligosaccharides interact with mouse gut microbiota to attenuate acute graft-versus-host disease
54. Health behaviors, obesity, and marital status among cancer survivors: a MEPS study
55. Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation
56. Efficacy of Probiotic Treatment as Post-Exposure Prophylaxis for COVID-19: A Double-Blind, Placebo Controlled Randomized Trial
57. Brincidofovir (CMX001) Toxicity Associated With Epithelial Apoptosis and Crypt Drop Out in a Hematopoietic Cell Transplant Patient: Challenges in Distinguishing Drug Toxicity From GVHD
58. HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group
59. The Diagnostic Yield of Site and Symptom-Based Biopsies for Acute Gastrointestinal Graft-Versus-Host Disease: A 5-Year Retrospective Review
60. Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia
61. Acute graft-versus-host disease: Are we close to bringing the bench to the bedside?
62. MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT
63. Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients
64. Daily Lactobacillus Probiotic versus Placebo in COVID-19-Exposed Household Contacts (PROTECT-EHC): A Randomized Clinical Trial
65. Enterococcus Intestinal Domination is Associated with Increased Mortality in the Acute Leukemia Chemotherapy Population
66. DART: Distance Assisted Recursive Testing.
67. Examining guidelines and new evidence in oncology nutrition: a position paper on gaps and opportunities in multimodal approaches to improve patient care
68. MI-Immune/1801: Lessons from an Ongoing, Multi-Center Trial Involving Biospecimen Collection for Prospective Microbiome and Immune Profiling in Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT
69. Allogeneic Stem Cell Transplantation with Omidubicel: Long-Term Follow-up from a Single Center
70. Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation
71. A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant
72. Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study
73. Unicameral Bone Cyst: A Retrospective Study of Three Surgical Treatments
74. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites
75. Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol
76. A Phase 1 Study of the Safety and Feasibility of Improving Cardiorespiratory Fitness through a Remotely Monitored, Mobile Health Supported High Intensity Interval Training Program (REMM-HIIT)
77. Correlation of Engraftment and Time from Melphalan Administration to Stem Cell Infusion
78. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant
79. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant
80. New approaches to manipulate minimal residual disease after allogeneic stem cell transplantation
81. Female Gender Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplant
82. Morphologic Leukemia-Free State in Acute Myeloid Leukemia Is Sufficient for Successful Allogeneic Hematopoietic Stem Cell Transplant
83. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites
84. Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality
85. House calls for stem cell transplant patients during the COVID-19 pandemic
86. Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation
87. The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD
88. Fibrinogen-Coated Albumin Nanospheres Prevent Thrombocytopenia-Related Bleeding
89. Microtransplantation in older patients with AML : A pilot study of safety, efficacy and immunologic effects
90. Transplant Physicians’ Attitudes on Candidacy for Allogeneic Hematopoietic Cell Transplantation (HCT) in Older Patients: The Need for a Standardized Geriatric Assessment (GA) Tool
91. Cognitive Impairment in Candidates for Allogeneic Hematopoietic Stem Cell Transplantation
92. Clinical and Neuroimaging Predictors of Post-Transplant Delirium
93. Phase II Trial of Pasireotide to Prevent GI Toxicity and Acute Gvhd in Allogeneic HSCT
94. Financial Incentives to Increase Stool Collection Rates for Microbiome Studies in Adult Bone Marrow Transplant Patients
95. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
96. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury–Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant
97. Machine Learning Applications in the Diagnosis of Benign and Malignant Hematological Diseases
98. The gut microbiota influences how circulating immune cells in humans change from one day to the next
99. The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future
100. Financial Incentives to Increase Stool Collection Rates for Microbiome Studies in Adult Bone Marrow Transplant Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.